Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Anukriti Jariwala 01/04/2023 Arpit Jariwala 18/03/2016 Sanskriti Jariwala 01/04/2023 Shweta Karkare Jariwala 18/03/2016 05 December 2025 The principal activity of the Company during the financial year was consultation and upper limb surgery. SC530137 2025-03-31 SC530137 bus:Director1 2025-03-31 SC530137 bus:Director2 2025-03-31 SC530137 bus:Director3 2025-03-31 SC530137 bus:Director4 2025-03-31 SC530137 2024-03-31 SC530137 core:CurrentFinancialInstruments 2025-03-31 SC530137 core:CurrentFinancialInstruments 2024-03-31 SC530137 core:ShareCapital 2025-03-31 SC530137 core:ShareCapital 2024-03-31 SC530137 core:RetainedEarningsAccumulatedLosses 2025-03-31 SC530137 core:RetainedEarningsAccumulatedLosses 2024-03-31 SC530137 core:OtherPropertyPlantEquipment 2024-03-31 SC530137 core:OtherPropertyPlantEquipment 2025-03-31 SC530137 2023-03-31 SC530137 bus:OrdinaryShareClass1 2025-03-31 SC530137 bus:OrdinaryShareClass2 2025-03-31 SC530137 bus:OrdinaryShareClass3 2025-03-31 SC530137 2024-04-01 2025-03-31 SC530137 bus:FilletedAccounts 2024-04-01 2025-03-31 SC530137 bus:SmallEntities 2024-04-01 2025-03-31 SC530137 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 SC530137 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 SC530137 bus:Director1 2024-04-01 2025-03-31 SC530137 bus:Director2 2024-04-01 2025-03-31 SC530137 bus:Director3 2024-04-01 2025-03-31 SC530137 bus:Director4 2024-04-01 2025-03-31 SC530137 core:OtherPropertyPlantEquipment core:BottomRangeValue 2024-04-01 2025-03-31 SC530137 core:OtherPropertyPlantEquipment core:TopRangeValue 2024-04-01 2025-03-31 SC530137 2023-04-01 2024-03-31 SC530137 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 SC530137 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 SC530137 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 SC530137 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 SC530137 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 SC530137 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 SC530137 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC530137 (Scotland)

UPPERLIMBCONSULTANT LTD

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH THE REGISTRAR

UPPERLIMBCONSULTANT LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025

Contents

UPPERLIMBCONSULTANT LTD

BALANCE SHEET

AS AT 31 MARCH 2025
UPPERLIMBCONSULTANT LTD

BALANCE SHEET (continued)

AS AT 31 MARCH 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 1,551 1,410
1,551 1,410
Current assets
Debtors 4 10,859 8,803
Cash at bank and in hand 5 74,853 133,346
85,712 142,149
Creditors: amounts falling due within one year 6 ( 65,728) ( 134,343)
Net current assets 19,984 7,806
Total assets less current liabilities 21,535 9,216
Provision for liabilities 7, 8 ( 388) ( 353)
Net assets 21,147 8,863
Capital and reserves
Called-up share capital 9 70 70
Profit and loss account 21,077 8,793
Total shareholders' funds 21,147 8,863

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of UpperLimbConsultant Ltd (registered number: SC530137) were approved and authorised for issue by the Board of Directors on 05 December 2025. They were signed on its behalf by:

Arpit Jariwala
Director
UPPERLIMBCONSULTANT LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
UPPERLIMBCONSULTANT LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

UpperLimbConsultant Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is C/O Johnston Carmichael Bishop's Court, 29 Albyn Place, Aberdeen, AB10 1YL, Scotland, United Kingdom.

The financial statements have been prepared under the historical cost convention and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business.

Revenue is recognised when the company has entitlement to the income in exchange for the provision of services.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 3 - 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Non-financial assets
At each balance sheet date, the company reviews its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include deposits held at call with banks.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Basic financial assets
Basic financial assets, which include debtors and bank balances, are measured at transaction price including transaction costs.

Basic financial liabilities
Basic financial liabilities, including creditors are recognised at transaction price.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

Provisions

Deferred tax provisions are recognised when the Company has a present obligation as a result of past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 4 4

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 April 2024 5,323 5,323
Additions 799 799
At 31 March 2025 6,122 6,122
Accumulated depreciation
At 01 April 2024 3,913 3,913
Charge for the financial year 658 658
At 31 March 2025 4,571 4,571
Net book value
At 31 March 2025 1,551 1,551
At 31 March 2024 1,410 1,410

4. Debtors

2025 2024
£ £
Trade debtors 10,859 8,803

5. Cash and cash equivalents

2025 2024
£ £
Cash at bank and in hand 74,853 133,346

6. Creditors: amounts falling due within one year

2025 2024
£ £
Taxation and social security 13,863 12,080
Other creditors 51,865 122,263
65,728 134,343

7. Provision for liabilities

2025 2024
£ £
Deferred tax 388 353

8. Deferred tax

2025 2024
£ £
At the beginning of financial year ( 353) ( 124)
Charged to the Statement of Income and Retained Earnings ( 35) ( 229)
At the end of financial year ( 388) ( 353)

9. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
40 A ordinary shares of £ 1.00 each 40 40
20 B ordinary shares of £ 1.00 each 20 20
10 C ordinary shares of £ 1.00 each 10 10
70 70

10. Related party transactions

Transactions with the entity's directors

2025 2024
£ £
Amounts owed to key management personnel 45,910 118,753

The above loan is unsecured, interest free and repayable on demand.